Improve speed, efficiency, and resilience in the development and manufacture of biopharmaceuticals with end-to-end bioprocess digital twins
The biopharmaceutical industry is rapidly evolving and there is an ongoing need to bring high quality medicines to the market faster, more efficiently, with flexible and sustainable processes. Organizations are increasingly looking towards digital transformation to help meet these challenges. Bioprocess digital twins are a key component of the solution: comprehensive virtual representations of bioprocesses that can be utilized across development, engineering and manufacturing to understand, predict and optimize performance, monitor operations and facilitate decision making.
They enable organizations to develop and produce medicines faster and more efficiently by replacing physical experimentation with in-silico modelling to design, optimize and scale-up biopharmaceutical manufacturing processes, reducing staff, material and lab costs. Deploying bioprocess digital twins in manufacturing for soft sensing, monitoring and real time optimization can then increase robustness, yield, and productivity. In this talk, we will provide an overview of the technical approach, describe common industrial applications, and discuss future perspectives, featuring highlights from a range of recent industry applications of bioprocess digital twins across the biopharmaceutical process lifecycle.
What this webinar covers?